Sorry, this activity has expired and is no longer available for CME credit. You may still enjoy the program.
CME Information
Provider Statement: This continuing medical education activity is provided by 
.
Support Statement: This activity is supported by an educational grant from Amgen.
Target Audience: The intended audience for this activity is cardiologists and other health care professionals involved in the treatment of patients with dyslipidemia.
Learning Objectives: Upon successful completion of this activity, participants should be better able to:
- Utilize PCSK9 inhibitors in accordance with the latest clinical evidence and guidelines.
- Examine the impact of PCSK9 inhibitors on CV risk reduction in patients with or without diabetes.
- Assess the impact of PCSK9 inhibitors on non–LDL-C lipid markers.
- Implement appropriate strategies to improve access to PCSK9 inhibitors.
Activity Chair:
Michael H. Davidson, MD, FACC, FACP, FNLA
Director of the Lipid Clinic
The University of Chicago, Pritzker School of Medicine
Chicago, IL
Faculty:
Alan S. Brown, MD, FACC, FAHA, FNLA
Director, Division of Cardiology
Advocate Lutheran General Hospital
Clinical Associate Professor
Loyola Stritch School of Medicine
Chicago, IL
Kausik Ray, MBChB, MD, MPhil, FRCP, FACC, FESC, FAHA
Professor of Public Health
School of Public Health, Imperial College London
Consultant Cardiologist
Imperial Centre for Cardiovascular Disease Prevention
Deputy Director Imperial Clinical Trials Unit and Head of
Commercial Trials Imperial College
London, United Kingdom
Reviewer:
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, January 10, 2019 to January 9, 2020.
How to Participate in This Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 4 out of 5 of the posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Activity Chair and Faculty report the following relationships:
Michael H. Davidson, MD, FACC, FACP, FNLA
Consulting Fee: Amgen, Novo Nordisk, Regeneron, Sanofi
Speakers Bureau: Amgen, Novo Nordisk, Regeneron, Sanofi
Alan S. Brown, MD, FACC, FAHA, FNLA
Consulting Fee: Akcea, Amgen, Kowa, Merck, Regeneron
Speakers Bureau: Amgen, Kowa, Regeneron, Sanofi-Aventis
Kausik Ray, MBChB, MD, MPhil, FRCP, FACC, FESC, FAHA
Consulting Fee: AbbVie, Amgen, Cerenis, Ionis, Lilly, Medco, Regeneron, Sanofi
Speakers Bureau: Algorithm, AstraZeneca, Boehringer Ingelheim, Cipla, Kowa, Pfizer, Takeda
Contracted Research: Amgen, Pfizer, Regeneron, Sanofi
Reviewer reports the following relationship(s):
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationship to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2019 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicoCME.com